Published in Control Clin Trials on December 01, 2000
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
The National Lung Screening Trial: overview and study design. Radiology (2010) 6.43
Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med (2013) 5.92
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach. Cancer Prev Res (Phila) (2008) 3.99
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst (2010) 3.16
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Comprehensive resequence analysis of a 136 kb region of human chromosome 8q24 associated with prostate and colon cancers. Hum Genet (2008) 2.41
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst (2011) 2.31
Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev (2010) 2.28
The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell (2009) 2.22
Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. J Clin Oncol (2014) 2.12
A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers. Cancer Epidemiol Biomarkers Prev (2009) 2.04
Shrinkage Estimators for Robust and Efficient Inference in Haplotype-Based Case-Control Studies. J Am Stat Assoc (2009) 2.00
Cumulative incidence of false-positive results in repeated, multimodal cancer screening. Ann Fam Med (2009) 1.94
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88
Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol (2009) 1.87
Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2008) 1.80
Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans. PLoS Genet (2011) 1.54
The association of telomere length and genetic variation in telomere biology genes. Hum Mutat (2010) 1.53
Longitudinal screening algorithm that incorporates change over time in CA125 levels identifies ovarian cancer earlier than a single-threshold rule. J Clin Oncol (2012) 1.48
A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes. PLoS Genet (2014) 1.48
Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol (2007) 1.41
Selecting patients for randomized trials: a systematic approach based on risk group. Trials (2006) 1.33
Lung cancer screening: the way forward. Br J Cancer (2008) 1.28
Retrospective analysis of haplotype-based case control studies under a flexible model for gene environment association. Biostatistics (2007) 1.26
Screening for ovarian cancer: recommendation statement. Ann Fam Med (2004) 1.24
Evaluation of polygenic risk scores for predicting breast and prostate cancer risk. Genet Epidemiol (2011) 1.23
Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer (2009) 1.22
Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 1.21
Collecting 48,000 CT exams for the lung screening study of the National Lung Screening Trial. J Digit Imaging (2008) 1.17
Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma. Cancer Res (2011) 1.16
Genome-wide association study of relative telomere length. PLoS One (2011) 1.16
Health-related quality of life in older adults at risk for disability. Am J Prev Med (2007) 1.16
A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma. Blood (2013) 1.14
Recommendations by Canadian urologists and radiation oncologists for the treatment of clinically localized prostate cancer. Can Urol Assoc J (2008) 1.07
Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan). Cancer Causes Control (2010) 1.07
A prospective evaluation of C-reactive protein levels and colorectal adenoma development. Cancer Epidemiol Biomarkers Prev (2011) 1.06
Protein biomarkers of ovarian cancer: the forest and the trees. Future Oncol (2012) 1.05
Creation of a CT Image Library for the Lung Screening Study of the National Lung Screening Trial. J Digit Imaging (2007) 1.04
A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33. Hum Genet (2009) 1.01
The prostate, lung, colorectal, and ovarian cancer screening trial and its associated research resource. J Natl Cancer Inst (2013) 0.98
HNF1B and JAZF1 genes, diabetes, and prostate cancer risk. Prostate (2010) 0.98
Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group. Gut (2005) 0.98
Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Mol Carcinog (2012) 0.97
Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr Cancer (2008) 0.96
Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study. Br J Cancer (2012) 0.96
Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma. Br J Cancer (2005) 0.96
Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst (2012) 0.96
Interaction among apoptosis-associated sequence variants and joint effects on aggressive prostate cancer. BMC Med Genomics (2012) 0.94
LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. Epigenetics (2013) 0.93
Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia. Carcinogenesis (2014) 0.93
Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut (2013) 0.92
Assessing the risk of ovarian malignancy in asymptomatic women with abnormal CA 125 and transvaginal ultrasound scans in the prostate, lung, colorectal, and ovarian screening trial. Obstet Gynecol (2013) 0.92
Factors related to use of prostate cancer screening: the Alberta Tomorrow Project. Open Med (2007) 0.91
Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Prev Res (Phila) (2011) 0.90
Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Hum Genet (2011) 0.90
Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). J Med Screen (2011) 0.89
Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. Am J Clin Nutr (2015) 0.88
Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer. Hum Genet (2009) 0.88
Meat-related mutagen exposure, xenobiotic metabolizing gene polymorphisms and the risk of advanced colorectal adenoma and cancer. Carcinogenesis (2012) 0.88
Metabolites of tobacco smoking and colorectal cancer risk. Carcinogenesis (2014) 0.87
CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants. Nat Med (2015) 0.87
Prostate mechanical imaging: a new method for prostate assessment. Urology (2008) 0.86
Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis (2010) 0.86
Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancer. Curr Opin Urol (2009) 0.85
Association of obesity with cardiovascular disease mortality in the PLCO trial. Prev Med (2013) 0.85
Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk. Cancer Causes Control (2013) 0.85
Total-body MR-imaging in oncology. Eur Radiol (2006) 0.84
Effects of baseline comorbidities on cancer screening trial adherence among older African American men. Cancer Epidemiol Biomarkers Prev (2008) 0.83
Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk. Eur J Cancer (2010) 0.82
Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. Carcinogenesis (2015) 0.81
Prostate-specific antigen screening and mortality from prostate cancer. J Gen Intern Med (2008) 0.81
Body mass index and mortality among blacks and whites adults in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial. Obesity (Silver Spring) (2013) 0.80
Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk. Int J Mol Epidemiol Genet (2010) 0.80
High spectral and spatial resolution MRI of age-related changes in murine prostate. Magn Reson Med (2008) 0.79
Men's knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study. BMC Cancer (2014) 0.79
GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes. Clin Exp Metastasis (2015) 0.79
Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry. Hum Genet (2012) 0.79
Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer (2016) 0.79
What we have learned from randomized trials of prostate cancer screening. Asian J Androl (2011) 0.78
Establishing a biologic specimens repository for reproductive clinical trials: technical aspects. Syst Biol Reprod Med (2011) 0.78
Biospecimens, biobanking and global cancer research collaborations. Ecancermedicalscience (2014) 0.78
Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma. World Rev Nutr Diet (2010) 0.78
Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy. Cancer Epidemiol (2011) 0.77
The use of multiphase nonlinear mixed models to define and quantify long-term changes in serum prostate-specific antigen: data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Ann Epidemiol (2015) 0.77
Urokinase-type plasminogen activator receptor: a beacon of malignancy? Clin Cancer Res (2008) 0.77
Evaluation of Oxidative Stress Response Related Genetic Variants, Pro-oxidants, Antioxidants and Prostate Cancer. AIMS Med Sci (2015) 0.77
Do cancer survivors develop healthier lifestyle behaviors than the cancer-free population in the PLCO study? J Cancer Surviv (2016) 0.77
Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer. Cell Syst (2016) 0.76
Cancer screening trials: nuts and bolts. Semin Oncol (2010) 0.76
A resequence analysis of genomic loci on chromosomes 1q32.1, 5p15.33, and 13q22.1 associated with pancreatic cancer risk. Pancreas (2013) 0.76
Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial. PLoS One (2015) 0.76
Dietary iron, iron homeostatic gene polymorphisms and the risk of advanced colorectal adenoma and cancer. Carcinogenesis (2014) 0.75
Colorectal cancer: screening. BMJ Clin Evid (2007) 0.75
Effects of electron-beam irradiation on buccal-cell DNA. Am J Hum Genet (2003) 0.75
Tracking and tracing of participants in two large cancer screening trials. Contemp Clin Trials (2012) 0.75
Active surveillance for prostate cancer: a legal perspective. Am J Clin Exp Urol (2014) 0.75
Management of relapsed ovarian cancer: a review. Springerplus (2016) 0.75
Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol (2015) 0.75
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77
Prostate cancer screening: what we know and what we need to know. Ann Intern Med (1993) 5.84
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
The role of increasing detection in the rising incidence of prostate cancer. JAMA (1995) 3.79
Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev (2001) 3.40
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst (1999) 3.35
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 3.29
Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol (2007) 3.24
Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst (1995) 2.83
Trends in biomarker research for cancer detection. Lancet Oncol (2001) 2.46
Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12
Evaluation of screening programmes for gynaecological cancer. Br J Cancer (1985) 2.06
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics (1992) 2.02
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1998) 1.91
Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care (1998) 1.88
Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst (1990) 1.86
Report on a Workshop of the UICC Project on Evaluation of Screening for Cancer. Int J Cancer (1990) 1.84
Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia. Am J Med (1982) 1.84
Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1994) 1.73
Study design in the evaluation of breast cancer imaging technologies. Acad Radiol (2000) 1.71
Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. J Urol (1994) 1.69
Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med (1996) 1.69
Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med (1987) 1.68
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening. Lancet (1991) 1.65
A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med (1996) 1.63
Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res (1997) 1.54
Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey. Cancer Causes Control (1993) 1.51
Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control (1994) 1.50
Occupational exposure to chlorinated aliphatic hydrocarbons and risk of astrocytic brain cancer. Am J Ind Med (1994) 1.48
Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst (1991) 1.42
Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res (1989) 1.41
Good for women, good for men, bad for people: Simpson's paradox and the importance of sex-specific analysis in observational studies. J Womens Health Gend Based Med (2001) 1.41
Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J Natl Cancer Inst (1994) 1.40
An EPR dosimetry method for rapid scanning of children following a radiation accident using deciduous teeth. Health Phys (1999) 1.39
Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires. Am J Epidemiol (2001) 1.35
Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res (1987) 1.34
Biochemical characterization of the amphotropic group of murine leukemia viruses. J Virol (1978) 1.31
Wood-related occupations, wood dust exposure, and sinonasal cancer. Am J Epidemiol (1986) 1.30
Cytogenetic effects of formaldehyde exposure in students of mortuary science. Cancer Epidemiol Biomarkers Prev (1993) 1.29
Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res (1998) 1.28
Multiple myeloma and family history of cancer among blacks and whites in the U.S. Cancer (1999) 1.25
Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years. Control Clin Trials (2000) 1.25
The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control (1998) 1.25
Tobacco, alcohol use, and risks of laryngeal and lung cancer by subsite and histologic type in Turkey. Cancer Causes Control (1997) 1.23
After a treatment breakthrough: a comparison of trial and population-based data for advanced testicular cancer. J Clin Oncol (1994) 1.21
Human herpesvirus 8 seroprevalence among prostate cancer case patients and control subjects. J Infect Dis (2007) 1.20
Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 1.18
Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo-controlled trial. J Pediatr (1983) 1.17
Induced abortion, bias, and breast cancer: why epidemiology hasn't reached its limit. J Natl Cancer Inst (1996) 1.16
An analysis of the mortality effect in a breast cancer screening study. Int J Epidemiol (1986) 1.15
Case-control studies of cancer screening: theory and practice. J Natl Cancer Inst (1998) 1.15
Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer. Gynecol Oncol (1990) 1.14
Mortality in chromium chemical production workers: a prospective study. Int J Epidemiol (1979) 1.14
The paired availability design for historical controls. BMC Med Res Methodol (2001) 1.13
Cohort study among workers exposed to benzene in China: II. Exposure assessment. Am J Ind Med (1994) 1.12
Increased aneusomy and long arm deletion of chromosomes 5 and 7 in the lymphocytes of Chinese workers exposed to benzene. Carcinogenesis (1998) 1.12
Concepts and problems in the evaluation of screening programs. J Chronic Dis (1981) 1.12
Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 1.11
Alcohol and pancreatic cancer in blacks and whites in the United States. Cancer Res (1995) 1.11
Epidemiologic evidence on the relationship between formaldehyde exposure and cancer. Scand J Work Environ Health (1990) 1.10
Efficacy of injectable and oral paste formulations of ivermectin against gastrointestinal parasites in ponies. Am J Vet Res (1982) 1.09
Design of the Prostate Cancer Prevention Trial (PCPT). Control Clin Trials (1995) 1.08
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol (1994) 1.07
Cancer of the nasal cavity and paranasal sinuses, and formaldehyde exposure. Int J Cancer (1986) 1.07
Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group. J Med Screen (1996) 1.06
Aflatoxin exposures in the industrial setting: an epidemiological study of mortality. Food Chem Toxicol (1984) 1.06
UICC Workshop on the evaluation of screening programmes for cancer. Int J Cancer (1984) 1.06
An epidemiologic study of early biologic effects of benzene in Chinese workers. Environ Health Perspect (1996) 1.05
Mortality of coke plant workers in The Netherlands. Br J Ind Med (1991) 1.05
Tobacco addiction: implications for treatment and cancer prevention. J Natl Cancer Inst (1997) 1.05
A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer (1993) 1.04
Occupational risk factors and prostate cancer in U.S. blacks and whites. Am J Ind Med (1998) 1.03
The case-control design and the assessment of the efficacy of cancer screening. J Clin Epidemiol (1991) 1.02
Chemoprevention. CA Cancer J Clin (1995) 1.02
Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 1.02
Early detection cancer research network. Lab Invest (2000) 1.01
Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3). J Clin Endocrinol Metab (2010) 1.00
Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med (1999) 1.00
Proportion of lung cancers in males, due to occupation, in different areas of the USA. Int J Cancer (1988) 1.00
A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma. J Clin Oncol (1991) 1.00
Analysis of the role of cancer prevention and control measures in reducing cancer mortality. J Natl Cancer Inst (1991) 0.99
UICC workshop of the Project on Evaluation of Screening Programmes for Gastrointestinal Cancer. Int J Cancer (1986) 0.99
Risk behaviours and benign prostatic hyperplasia. BJU Int (2004) 0.99
Occupational exposure to pesticides and pancreatic cancer. Am J Ind Med (2001) 0.97
Dietary factors and the risk of squamous cell esophageal cancer among black and white men in the United States. Cancer Causes Control (1998) 0.97
Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study. Cancer (1983) 0.97
Multiple myeloma among Blacks and Whites in the United States: role of cigarettes and alcoholic beverages. Cancer Causes Control (1997) 0.97
Diet and nutrition as risk factors for multiple myeloma among blacks and whites in the United States. Cancer Causes Control (2001) 0.97
An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ Health Perspect (1996) 0.97
Mortality experience of haematite mine workers in China. Br J Ind Med (1990) 0.97
The management of primary lymphoma of bone. Radiother Oncol (1987) 0.96
Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study. Br J Cancer (2012) 0.96
Mortality among workers exposed to cutting oil mist: update of previous reports. Am J Ind Med (2000) 0.96
Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes Control (1994) 0.96